Search results for PX-TA1387
Showing 1 – 10 of1products

ID: BAB866387367
Cergutuzumab Biosimilar – Anti-CEACAM5, CEA, CD66e mAb – Research Grade, ProteoGenix, PX-TA1387
Description of Cergutuzumab Biosimilar - Anti-CEACAM5, CEA, CD66e mAb - Research Grade General information on Anti-CEACAM5/CEA/CD66e[Homo sapiens] (Cergutuzumab) Monoclonal Antibody Cergutuzumab is investigated for the treatment of Advanced and/or Metastatic Solid Tumors.
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.
